Adam Christopher Mueller

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Babar Bashir · 2 shared papers, 2023–2024 · strength 0.57
   • Paper Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape. DOI 10.1200/op.22.00620↗
   • Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y↗
2. Karyn A. Goodman · 4 shared papers, 2021–2022 · strength 0.43
   • Paper Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline r… DOI 10.1016/j.hpb.2020.11.004↗
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
3. Marco Del Chiaro · 4 shared papers, 2021–2022 · strength 0.43
   • Paper Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline r… DOI 10.1016/j.hpb.2020.11.004↗
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
4. Richard David Schulick · 4 shared papers, 2021–2022 · strength 0.43
   • Paper Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline r… DOI 10.1016/j.hpb.2020.11.004↗
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
5. Wells A. Messersmith · 4 shared papers, 2021–2022 · strength 0.43
   • Paper Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline r… DOI 10.1016/j.hpb.2020.11.004↗
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
6. Miles Piper · 3 shared papers, 2021–2022 · strength 0.30
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
   • Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892↗
7. Sana D. Karam · 3 shared papers, 2021–2022 · strength 0.30
   • Paper Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pan… DOI 10.1158/1078-0432.ccr-21-2767↗
   • Paper Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor ce… DOI 10.1007/s00262-020-02701-w↗
   • Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892↗
8. Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
9. Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
10. John Ng · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
11. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
12. Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
13. Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
14. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
15. Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
16. Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
17. Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
18. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
19. Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
20. Parag Jitendra Parikh · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
21. Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
22. Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
23. Adam Eugene Snook · 1 shared paper, 2022 · strength 0.26
    • Paper The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies tar… DOI 10.2217/imt-2022-0046↗
24. Robert Hughes · 1 shared paper, 2022 · strength 0.26
    • Paper The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies tar… DOI 10.2217/imt-2022-0046↗
25. Martin D. McCarter · 2 shared papers, 2021 · strength 0.21
    • Paper Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline r… DOI 10.1016/j.hpb.2020.11.004↗
    • Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.